Greenwich LifesciencesInc Number of Employees vs. Total Debt

GLSI
 Stock
  

USD 13.51  0.20  1.46%   

For Greenwich LifesciencesInc profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Greenwich LifesciencesInc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Greenwich LifesciencesInc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Greenwich LifesciencesInc's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Greenwich LifesciencesInc over time as well as its relative position and ranking within its peers. Please check Risk vs Return Analysis.
  
Is Greenwich LifesciencesInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich LifesciencesInc. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich LifesciencesInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Greenwich LifesciencesInc is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich LifesciencesInc's value that differs from its market value or its book value, called intrinsic value, which is Greenwich LifesciencesInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich LifesciencesInc's market value can be influenced by many factors that don't directly affect Greenwich LifesciencesInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich LifesciencesInc's value and its price as these two are different measures arrived at by different means. Investors typically determine Greenwich LifesciencesInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich LifesciencesInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Greenwich LifesciencesInc Total Debt vs. Number of Employees Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Greenwich LifesciencesInc's current stock value. Our valuation model uses many indicators to compare Greenwich LifesciencesInc value to that of its competitors to determine the firm's financial worth.
Greenwich LifesciencesInc is one of the top stocks in number of employees category among related companies. It is rated as one of the top companies in total debt category among related companies making up about  211,717  of Total Debt per Number of Employees. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Greenwich LifesciencesInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Greenwich LifesciencesInc's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Greenwich LifesciencesInc's earnings, one of the primary drivers of an investment's value.

Greenwich Number of Employees vs. Competition

Greenwich LifesciencesInc is one of the top stocks in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 197,202. Greenwich LifesciencesInc adds roughly 3.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Greenwich Total Debt vs. Number of Employees

Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Greenwich LifesciencesInc 
Number of Employees 
 = 
Full Time 
+  
Part Time 
3
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Greenwich LifesciencesInc 
Total Debt 
 = 
Bonds 
+  
Notes 
635.15 K
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Greenwich Total Debt vs Competition

Greenwich LifesciencesInc is rated as one of the top companies in total debt category among related companies. Total debt of Health Care industry is currently estimated at about 14.66 Billion. Greenwich LifesciencesInc adds roughly 635,150 in total debt claiming only tiny portion of equities under Health Care industry.
Total debt  Workforce  Revenue  Capitalization  Valuation

Greenwich LifesciencesInc Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Greenwich LifesciencesInc, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Greenwich LifesciencesInc will eventually generate negative long term returns. The profitability progress is the general direction of Greenwich LifesciencesInc's change in net profit over the period of time. It can combine multiple indicators of Greenwich LifesciencesInc, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2neu-expressing cancers. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas. Greenwich Lifesciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

Greenwich Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Greenwich LifesciencesInc. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Greenwich LifesciencesInc position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Greenwich LifesciencesInc's important profitability drivers and their relationship over time.

Use Greenwich LifesciencesInc in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Greenwich LifesciencesInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Greenwich LifesciencesInc will appreciate offsetting losses from the drop in the long position's value.

Greenwich LifesciencesInc Pair Trading

Greenwich LifesciencesInc Pair Trading Analysis

The ability to find closely correlated positions to Greenwich LifesciencesInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Greenwich LifesciencesInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Greenwich LifesciencesInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Greenwich LifesciencesInc to buy it.
The correlation of Greenwich LifesciencesInc is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Greenwich LifesciencesInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Greenwich LifesciencesInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Greenwich LifesciencesInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Greenwich LifesciencesInc position

In addition to having Greenwich LifesciencesInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Insurance Thematic Idea Now

Insurance
Insurance Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Insurance theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Theme or any other thematic opportunities.
View All  Next Launch
Please check Risk vs Return Analysis. You can also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for analysis

When running Greenwich LifesciencesInc price analysis, check to measure Greenwich LifesciencesInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich LifesciencesInc is operating at the current time. Most of Greenwich LifesciencesInc's value examination focuses on studying past and present price action to predict the probability of Greenwich LifesciencesInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Greenwich LifesciencesInc's price. Additionally, you may evaluate how the addition of Greenwich LifesciencesInc to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
To fully project Greenwich LifesciencesInc's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Greenwich LifesciencesInc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Greenwich LifesciencesInc's income statement, its balance sheet, and the statement of cash flows.
Potential Greenwich LifesciencesInc investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Greenwich LifesciencesInc investors may work on each financial statement separately, they are all related. The changes in Greenwich LifesciencesInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Greenwich LifesciencesInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.